Effects of non-invasive neuromodulation on sleep quality and recovery in elite female football players
Effects of Applied Superficial Electrical Neuromodulation (NESA) on sleep quality and recovery in elite female athletes: a randomized controlled pilot trial
University of Las Palmas de Gran Canaria
20 participants
Dec 17, 2025
Interventional
Conditions
Summary
This study aims to examine whether a non-invasive neuromodulation technique can improve sleep quality and recovery in elite female football players. The intervention uses the NESA® XSIGNAL® microcurrent system, which delivers very low-intensity electrical impulses through electrodes placed on the hands, feet, and a small number of additional body sites. The treatment is completely painless and aims to stimulate the autonomic nervous system to promote better sleep and physiological recovery after training and competition. Twelve professional female football players will be randomly assigned to either an intervention group, receiving the NESA® neuromodulation sessions, or a control group, continuing their usual training without the device. The treatment lasts eight weeks (four sessions per week, 60 minutes each). The researchers will assess sleep quality (using the Pittsburgh Sleep Quality Index), heart rate variability (a marker of autonomic balance), neuromuscular performance (sprint and jump tests), hormonal markers (salivary cortisol), and perceived anxiety before and after the intervention. The results may provide valuable information on whether this non-invasive and safe technology can be used to support recovery and performance in elite female athletes, contributing to evidence-based physiotherapy and sports medicine practices.
Eligibility
Plain Language Summary
Simplified for easier understanding
This is a simplified summary. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
articipants allocated to the intervention will receive non-invasive microcurrent neuromodulation using the NESA device system. Standardized surface electrodes are placed on both hands and both feet, plus one directing electrode that varies by phase (see below). Sessions are delivered four times per week, 60 minutes each, for 8 weeks (32 sessions total). Intensity: device “Low” setting (microcurrent; not perceptible to participants). Frequencies: within 1–15 Hz, delivered as bioelectric pulse trains (up to ~19,000 pulses/min); frequency may be fixed or variable within this range by program. Provider: Licensed physiotherapists trained in the clinical use of the NESA system and not involved in outcome assessment. Five progressive phases (program order and durations within each 60-min session): - Phase 1 (Week 1; acclimation; directing electrode at C6–C7): P1: 15 min. P2: 15 min. P7: 15 min. P8: 15 min. - Phase 2 (Week 2; circadian/sleep focus; directing electrode frontal midline): P2: 20 min. P4: 20 min. P5: 20 min. - Phase 3 (Weeks 3–4; autonomic regulation; directing electrode at C6–C7): P7: 40 min. P8: 20 min. - Phase 4 (Weeks 5–7; performance/recovery; directing electrode at C6–C7): P2: 15 min. P7: 30 min. P8: 15 min. - Phase 5 (Week 8; consolidation; directing electrode at C6–C7): P7: 45 min. P8: 15 min. Programs used and how they differ (as per protocol): - Program 1 (P1): Alternating stimulus times with frequencies ~3.85–7.69 Hz, sequential delivery across the 24 electrodes, multiple pauses, alternating polarity. - Program 2 (P2): Frequencies ~1.14–1.96 Hz with input pathways emphasising distal channels of upper/lower limbs; sequencing oriented ventrally. - Program 4 (P4): Preset pattern with lower-frequency ranges and sustained cycles to support sleep-related scheduling (used in circadian phase). - Program 5 (P5): Preset pattern with progressive sequencing/duty cycle adjustments (used in circadian phase). - Program 7 (P7): Alternating stimulus times with frequencies ~1.92–14.29 Hz, symmetric positive/negative pulses; multi-channel sequencing. - Program 8 (P8): Sequential stimuli with stable frequency ~7.69 Hz, symmetric polarity across channels. Adherence/fidelity monitoring: - Attendance logs for each session (start/stop times). - Electrode placement checklist (location, integrity, skin preparation). - Session record of program(s), order, and exact programmed durations. - Random internal audits of =10% of sessions by a senior investigator. - Documentation of any protocol deviations.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12625001385437